SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 332 filers reported holding SEATTLE GENETICS INC in Q3 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,790,000 | +25.7% | 34,700 | +9.1% | 0.02% | +20.0% |
| Q2 2020 | $5,403,000 | +56.1% | 31,800 | +6.0% | 0.02% | +33.3% |
| Q1 2020 | $3,461,000 | +1466.1% | 30,000 | +669.2% | 0.02% | +1400.0% |
| Q4 2018 | $221,000 | -90.1% | 3,900 | -86.6% | 0.00% | -90.0% |
| Q3 2018 | $2,236,000 | – | 29,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 44,100,294 | $2,381,857,000 | 21.61% |
| Lagoda Investment Management, L.P. | 567,057 | $30,627,000 | 9.21% |
| Redmile Group, LLC | 1,781,470 | $96,217,000 | 7.65% |
| Boxer Capital, LLC | 232,600 | $12,563,000 | 5.63% |
| NEXTHERA CAPITAL LP | 111,500 | $6,022,000 | 3.70% |
| Eventide Asset Management | 835,506 | $45,126,000 | 2.76% |
| WASATCH ADVISORS LP | 2,844,908 | $153,653,000 | 2.29% |
| Opus Point Partners Management, LLC | 67,953 | $3,670,000 | 2.06% |
| CORRADO ADVISORS, LLC | 43,050 | $2,325,000 | 1.48% |
| Baillie Gifford | 16,795,793 | $907,142,000 | 1.42% |